Salbutamol
Clinical data | |
---|---|
Trade names | Ventolin, Proventil, ProAir, others[1] |
Other names | Albuterol (USAN US) |
AHFS/Drugs.com | Monograph |
MedlinePlus | a607004 |
License data | |
Pregnancy category | |
Routes of administration | By mouth, Inhalational, Intravenous |
Drug class | Beta2-adrenergic agonist |
ATC code | |
Legal status | |
Legal status | |
Pharmacokinetic data | |
Metabolism | Liver |
Onset of action | <15 min (inhaled), <30 min (pill)[8] |
Elimination half-life | 3.8–6 hrs (inhaled); 5–7.2 hrs (pill)[8] |
Duration of action | 3–6 hrs (inhaled); up to 8 hrs (pill)[8] |
Excretion | Kidney |
Identifiers | |
| |
JSmol) | |
Chirality | Racemic mixture |
| |
| |
(what is this?) (verify) |
Salbutamol, also known as albuterol and sold under the brand name Ventolin among others,
Common side effects include shakiness, headache,
Salbutamol was patented in 1966 in Britain and became commercially available in the UK in 1969.
Medical uses
Salbutamol is typically used to treat
As a β2 agonist, salbutamol also has use in obstetrics. Intravenous salbutamol can be used as a tocolytic to relax the uterine smooth muscle to delay premature labor. While preferred over agents such as atosiban and ritodrine, its role has largely been replaced by the calcium channel blocker nifedipine, which is more effective and better tolerated.[18]
Salbutamol has been used to treat acute hyperkalemia, as it stimulates potassium flow into cells, thus lowering the potassium in the blood.[9]
Adverse effects
The most common side effects are fine
Salbutamol metered dose inhalers have been described as the "single biggest source of carbon emissions from NHS medicines prescribing" due to the propellants used in the inhalers. Dry powder inhalers are recommended as a low-carbon alternative.[20]
Pharmacology
The tertiary
Salbutamol is either filtered out by the kidneys directly or is first metabolized into the 4′-O-sulfate, which is excreted in the urine.[10]
Chemistry
Salbutamol is sold as a
The direct separation of Salbutamol enantiomers and the control of enantiomeric purity has been described by thin-layer chromatography.[28]
History
Salbutamol was discovered in 1966, by a team led by
The
In February 2020, the U.S. Food and Drug Administration (FDA) approved the first generic of an albuterol sulfate inhalation aerosol for the treatment or prevention of bronchospasm in people four years of age and older with reversible obstructive airway disease and the prevention of exercise-induced bronchospasm in people four years of age and older.[31][32] The FDA granted approval of the generic albuterol sulfate inhalation aerosol to Perrigo Pharmaceutical.[31]
In April 2020, the FDA approved the first generic of Proventil HFA (albuterol sulfate) metered dose inhaler, 90 μg per inhalation, for the treatment or prevention of bronchospasm in patients four years of age and older who have reversible obstructive airway disease, as well as the prevention of exercise-induced bronchospasm in this age group.[33] The FDA granted approval of this generic albuterol sulfate inhalation aerosol to Cipla Limited.[33]
Society and culture
In 2020, generic versions were approved in the United States.[31][33]
Names
Salbutamol is the international nonproprietary name (INN) while albuterol is the United States Adopted Name (USAN).[34] The drug is usually manufactured and distributed as the sulfate salt (salbutamol sulfate).
It was first sold by Allen & Hanburys (UK) under the brand name Ventolin, and has been used for the treatment of asthma ever since.[35] The drug is marketed under many names worldwide.[1]
Misuse
Albuterol and other beta-2 adrenergic agonists are used by some recreational bodybuilders.[36][37]
Doping
As of 2011[update] there was no evidence that an increase in physical performance occurs after inhaling salbutamol, but there are various reports for benefit when delivered orally or intravenously.[38][39] In spite of this, salbutamol required "a declaration of Use in accordance with the International Standard for Therapeutic Use Exemptions" under the 2010 WADA prohibited list. This requirement was relaxed when the 2011 list was published to permit the use of "salbutamol (maximum 1600 micrograms over 24 hours) and salmeterol when taken by inhalation in accordance with the manufacturers' recommended therapeutic regimen."[40][41]
Abuse of the drug may be confirmed by detection of its presence in plasma or urine, typically exceeding 1,000 ng/mL. The window of detection for urine testing is on the order of just 24 hours, given the relatively short elimination half-life of the drug,[42][43][44] estimated at between 5 and 6 hours following oral administration of 4 mg.[22]
Research
Salbutamol has been studied in subtypes of congenital myasthenic syndrome associated with mutations in Dok-7.[45]
It has also been tested in a trial aimed at treatment of spinal muscular atrophy; it is speculated to modulate the alternative splicing of the SMN2 gene, increasing the amount of the SMN protein, the deficiency of which is regarded as a cause of the disease.[46][47]
Albuterol increases energy expenditure by 10-15 percent at a therapeutic dose for asthma and around 25 percent at a higher, oral dose. In several human studies, albuterol increased lean body mass, reduced fat mass, and caused lipolysis; it has been studied for use as an anti-obesity and anti-muscle wasting medication when taken orally.[48][49]
Veterinary use
Salbutamol's low toxicity makes it safe for other animals and thus is the medication of choice for treating acute airway obstruction in most species.[26] It is usually used to treat bronchospasm or coughs in cats and dogs and used as a bronchodilator in horses with recurrent airway obstruction; it can also be used in emergencies to treat asthmatic cats.[50][51]
Toxic effects require an extremely high dose, and most overdoses are due to dogs chewing on and puncturing an inhaler or nebulizer vial.[52]
References
- ^ a b c "Salbutamol". Drugs.com. Archived from the original on 30 March 2016. Retrieved 11 April 2016.
- ^ Thereaputic Goods Administration (19 December 2018). "Prescribing medicines in pregnancy database". Australian Government.
- ^ "Albuterol Use During Pregnancy". Drugs.com. 8 March 2019. Retrieved 21 December 2019.
- FDA. Retrieved 22 October 2023.
- ^ Thereaputic Goods Administration. "Poisons Standard October 2017". Australian Government.
- ^ "Prescription Drug List". Government of Canada. 23 October 2014.
- ^ "Respiratory health". Health Canada. 9 May 2018. Retrieved 13 April 2024.
- ^ a b c d e f g h i j k l m n "Albuterol". Drugs.com. The American Society of Health-System Pharmacists. Archived from the original on 8 December 2015. Retrieved 2 December 2015.
- ^ PMID 15846652.
- ^ S2CID 2070868. Archived from the original(PDF) on 8 September 2017.
- ISBN 9781608317080. Archivedfrom the original on 8 December 2015.
- ISBN 9780941901215. Archivedfrom the original on 8 December 2015.
- ISBN 9783527607495.
- hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.
- ^ "The Top 300 of 2021". ClinCalc. Archived from the original on 15 January 2024. Retrieved 14 January 2024.
- ^ "Albuterol - Drug Usage Statistics". ClinCalc. Retrieved 14 January 2024.
- ^ Hatfield H. "Asthma: The Rescue Inhaler -- Now a Cornerstone of Asthma Treatment". WebMD. Archived from the original on 16 July 2017. Retrieved 27 June 2017.
- ISBN 978-0-9578521-4-3.
- ^ ISBN 978-0-85369-778-7.
- ^ "Primary care networks incentivised to switch patients to more environmentally friendly inhalers". Pharmaceutical Journal. 3 September 2021. Retrieved 16 October 2021.
- from the original on 8 September 2017.
- ^ a b "Albuterol Sulfate". Rx List: The Internet Drug Index. Archived from the original on 18 July 2014. Retrieved 13 July 2014.
- ISBN 9781416028888.
- ^ "Albuterol - Medical Countermeasures Database". CHEMM. US Department of Health and Human Services. 28 April 2017. Archived from the original on 3 August 2017. Retrieved 23 June 2017.
- ^ Mehta A. "Medicinal Chemistry of the Peripheral Nervous System – Adrenergics and Cholinergics their Biosynthesis, Metabolism, and Structure Activity Relationships". Archived from the original on 4 November 2010. Retrieved 20 October 2010.
- ^ a b "Inhalation Therapy of Airway Disease". Merck Veterinary Manual. Archived from the original on 25 June 2017. Retrieved 22 June 2017.
- PMID 28652557.
- )
- ^ "Sir David Jack, who has died aged 87, was the scientific brain behind the rise of the pharmaceuticals company Glaxo". The Telegraph. 17 November 2011. Archived from the original on 25 November 2011.
- S2CID 71908898.
- ^ a b c "FDA approves first generic of ProAir HFA". U.S. Food and Drug Administration (FDA) (Press release). 24 February 2020. Retrieved 24 February 2020. This article incorporates text from this source, which is in the public domain.
- ^ "Albuterol Sulfate: FDA-Approved Drugs". U.S. Food and Drug Administration (FDA). Retrieved 26 February 2020.
- ^ a b c "FDA Approves First Generic of a Commonly Used Albuterol Inhaler to Treat and Prevent Bronchospasm". U.S. Food and Drug Administration (FDA) (Press release). 8 April 2020. Retrieved 10 April 2020. This article incorporates text from this source, which is in the public domain.
- ^ "Salbutamol". PubChem. U.S. National Library of Medicine.
- ^ "Ventolin remains a breath of fresh air for asthma sufferers, after 40 years" (PDF). The Pharmaceutical Journal. 279 (7473): 404–405. Archived from the original (PDF) on 15 October 2007.
- S2CID 229695809.
- S2CID 81614300.
- S2CID 189906919.
- PMID 18500380.
- ^ "The 2010 Prohibited List International Standard" (PDF). WADA. Archived from the original (PDF) on 11 September 2013. Retrieved 20 October 2010.
- ^ "The 2011 Prohibited List International Standard" (PDF). WADA. Archived (PDF) from the original on 13 May 2012. Retrieved 22 May 2012.
- ISBN 978-0-9626523-6-3.
- from the original on 17 July 2011.
- S2CID 30402521.
- PMID 21952943.
- PMID 22031667.
- PMID 22134788.
- S2CID 239457357.
- S2CID 210842115.
- ISBN 9780470959640.
- ISBN 9780702054235. Archivedfrom the original on 8 September 2017.
- ISBN 9780323240741. Archivedfrom the original on 8 September 2017.